Henric Bjarke

2022

In 2022, Henric Bjarke earned a total compensation of $958.9K as Former Senior Vice President and Chief Operating Officer at Inozyme Pharma, a 29% decrease compared to previous year.

Compensation breakdown

Option Awards$491,999
Salary$458,615
Other$8,282
Total$958,896

Bjarke received $492K in option awards, accounting for 51% of the total pay in 2022.

Bjarke also received $458.6K in salary and $8.3K in other compensation.

Rankings

In 2022, Henric Bjarke's compensation ranked 3,113th out of 5,736 executives tracked by ExecPay. In other words, Bjarke earned more than 45.7% of executives.

ClassificationRankingPercentile
All
3,113
out of 5,736
46th
Division
Manufacturing
1,752
out of 3,125
44th
Major group
Chemicals And Allied Products
824
out of 1,416
42nd
Industry group
Drugs
769
out of 1,317
42nd
Industry
Pharmaceutical Preparations
559
out of 963
42nd
Source: SEC filing on April 27, 2023.

Bjarke's colleagues

We found two more compensation records of executives who worked with Henric Bjarke at Inozyme Pharma in 2022.

2022

Axel Bolte

Inozyme Pharma

Chief Executive Officer

2022

Sanjay Subramanian

Inozyme Pharma

Chief Financial Officer

News

In-depth

You may also like